Journal
MODERN PATHOLOGY
Volume 24, Issue -, Pages S34-S43Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/modpathol.2010.167
Keywords
BRAF; cancer; RET/PTC; RAS; thyroid
Categories
Ask authors/readers for more resources
In the recent years, a large number of molecular alterations in thyroid cancer has been discovered and characterized. Some of these markers may have significant diagnostic utility, can be used for tumor prognostication, and serve as potential therapeutic targets. The diagnostic utility of these markers is of particular importance in thyroid fine-needle aspiration samples. Some molecular markers, such as BRAF, offer help in risk stratification and can be potentially used to optimize surgical and postsurgical management of patients with thyroid cancer. This review discusses major molecular alterations known to occur in thyroid cancer, focusing on those markers that have been extensively characterized, carry clinical significance, and are being introduced into pathology practice. Modern Pathology (2011) 24, S34-S43; doi:10.1038/modpathol.2010.167
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available